EW-3 |
Growth Inhibition Assay |
|
|
|
Inhibition of human EW-3 cell growth in a cell viability assay, IC50 = 0.0358 μM. |
SANGER |
H9 |
Growth Inhibition Assay |
|
|
|
Inhibition of human H9 cell growth in a cell viability assay, IC50 = 0.06019 μM. |
SANGER |
KARPAS-45 |
Growth Inhibition Assay |
|
|
|
Inhibition of human KARPAS-45 cell growth in a cell viability assay, IC50 = 0.16525 μM. |
SANGER |
NCI-H720 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H720 cell growth in a cell viability assay, IC50 = 0.17194 μM. |
SANGER |
CTV-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human CTV-1 cell growth in a cell viability assay, IC50 = 0.47872 μM. |
SANGER |
DU-4475 |
Growth Inhibition Assay |
|
|
|
Inhibition of human DU-4475 cell growth in a cell viability assay, IC50 = 0.50417 μM. |
SANGER |
A172 |
Growth Inhibition Assay |
|
|
|
Inhibition of human A172 cell growth in a cell viability assay, IC50 = 0.51705 μM. |
SANGER |
EW-18 |
Growth Inhibition Assay |
|
|
|
Inhibition of human EW-18 cell growth in a cell viability assay, IC50 = 0.62211 μM. |
SANGER |
KU812 |
Growth Inhibition Assay |
|
|
|
Inhibition of human KU812 cell growth in a cell viability assay, IC50 = 0.62623 μM. |
SANGER |
KP-N-YS |
Growth Inhibition Assay |
|
|
|
Inhibition of human KP-N-YS cell growth in a cell viability assay, IC50 = 0.68223 μM. |
SANGER |
SBC-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SBC-1 cell growth in a cell viability assay, IC50 = 0.69524 μM. |
SANGER |
ECC10 |
Growth Inhibition Assay |
|
|
|
Inhibition of human ECC10 cell growth in a cell viability assay, IC50 = 0.70094 μM. |
SANGER |
GAMG |
Growth Inhibition Assay |
|
|
|
Inhibition of human GAMG cell growth in a cell viability assay, IC50 = 0.74717 μM. |
SANGER |
NCI-H209 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H209 cell growth in a cell viability assay, IC50 = 0.7682 μM. |
SANGER |
MC-IXC |
Growth Inhibition Assay |
|
|
|
Inhibition of human MC-IXC cell growth in a cell viability assay, IC50 = 0.79589 μM. |
SANGER |
HSC-3 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HSC-3 cell growth in a cell viability assay, IC50 = 0.81769 μM. |
SANGER |
IST-SL1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human IST-SL1 cell growth in a cell viability assay, IC50 = 0.84574 μM. |
SANGER |
LU-139 |
Growth Inhibition Assay |
|
|
|
Inhibition of human LU-139 cell growth in a cell viability assay, IC50 = 0.84958 μM. |
SANGER |
ML-2 |
Growth Inhibition Assay |
|
|
|
Inhibition of human ML-2 cell growth in a cell viability assay, IC50 = 0.85575 μM. |
SANGER |
CAL-62 |
Growth Inhibition Assay |
|
|
|
Inhibition of human CAL-62 cell growth in a cell viability assay, IC50 = 0.88152 μM. |
SANGER |
HL-60 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HL-60 cell growth in a cell viability assay, IC50 = 0.88362 μM. |
SANGER |
KY821 |
Growth Inhibition Assay |
|
|
|
Inhibition of human KY821 cell growth in a cell viability assay, IC50 = 0.88812 μM. |
SANGER |
ES7 |
Growth Inhibition Assay |
|
|
|
Inhibition of human ES7 cell growth in a cell viability assay, IC50 = 0.91607 μM. |
SANGER |
MV-4-11 |
Growth Inhibition Assay |
|
|
|
Inhibition of human MV-4-11 cell growth in a cell viability assay, IC50 = 0.97897 μM. |
SANGER |
Daoy |
Growth Inhibition Assay |
|
|
|
Inhibition of human Daoy cell growth in a cell viability assay, IC50 = 0.98767 μM. |
SANGER |
EoL-1-cell |
Growth Inhibition Assay |
|
|
|
Inhibition of human EoL-1-cell cell growth in a cell viability assay, IC50 = 1.01878 μM. |
SANGER |
TGW |
Growth Inhibition Assay |
|
|
|
Inhibition of human TGW cell growth in a cell viability assay, IC50 = 1.05124 μM. |
SANGER |
LAMA-84 |
Growth Inhibition Assay |
|
|
|
Inhibition of human LAMA-84 cell growth in a cell viability assay, IC50 = 1.12794 μM. |
SANGER |
KOSC-2 |
Growth Inhibition Assay |
|
|
|
Inhibition of human KOSC-2 cell growth in a cell viability assay, IC50 = 1.13385 μM. |
SANGER |
A549 |
Growth Inhibition Assay |
|
|
|
Inhibition of human A549 cell growth in a cell viability assay, IC50 = 1.30955 μM. |
SANGER |
CTB-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human CTB-1 cell growth in a cell viability assay, IC50 = 1.44679 μM. |
SANGER |
NCI-H292 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H292 cell growth in a cell viability assay, IC50 = 1.46069 μM. |
SANGER |
LoVo |
Growth Inhibition Assay |
|
|
|
Inhibition of human LoVo cell growth in a cell viability assay, IC50 = 1.46755 μM. |
SANGER |
BFTC-905 |
Growth Inhibition Assay |
|
|
|
Inhibition of human BFTC-905 cell growth in a cell viability assay, IC50 = 1.56332 μM. |
SANGER |
BE-13 |
Growth Inhibition Assay |
|
|
|
Inhibition of human BE-13 cell growth in a cell viability assay, IC50 = 1.58709 μM. |
SANGER |
KE-37 |
Growth Inhibition Assay |
|
|
|
Inhibition of human KE-37 cell growth in a cell viability assay, IC50 = 1.59478 μM. |
SANGER |
HN |
Growth Inhibition Assay |
|
|
|
Inhibition of human HN cell growth in a cell viability assay, IC50 = 1.61368 μM. |
SANGER |
A3-KAW |
Growth Inhibition Assay |
|
|
|
Inhibition of human A3-KAW cell growth in a cell viability assay, IC50 = 1.62834 μM. |
SANGER |
NEC8 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NEC8 cell growth in a cell viability assay, IC50 = 1.70115 μM. |
SANGER |
Ramos-2G6-4C10 |
Growth Inhibition Assay |
|
|
|
Inhibition of human Ramos-2G6-4C10 cell growth in a cell viability assay, IC50 = 1.70444 μM. |
SANGER |
NB10 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NB10 cell growth in a cell viability assay, IC50 = 1.7763 μM. |
SANGER |
NBsusSR |
Growth Inhibition Assay |
|
|
|
Inhibition of human NBsusSR cell growth in a cell viability assay, IC50 = 1.82961 μM. |
SANGER |
ES4 |
Growth Inhibition Assay |
|
|
|
Inhibition of human ES4 cell growth in a cell viability assay, IC50 = 1.85143 μM. |
SANGER |
ES8 |
Growth Inhibition Assay |
|
|
|
Inhibition of human ES8 cell growth in a cell viability assay, IC50 = 1.87724 μM. |
SANGER |
CHL-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human CHL-1 cell growth in a cell viability assay, IC50 = 1.95792 μM. |
SANGER |
NCI-H2029 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H2029 cell growth in a cell viability assay, IC50 = 1.97241 μM. |
SANGER |
YKG-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human YKG-1 cell growth in a cell viability assay, IC50 = 1.98432 μM. |
SANGER |
BV-173 |
Growth Inhibition Assay |
|
|
|
Inhibition of human BV-173 cell growth in a cell viability assay, IC50 = 1.98666 μM. |
SANGER |
697 |
Growth Inhibition Assay |
|
|
|
Inhibition of human 697 cell growth in a cell viability assay, IC50 = 2.02228 μM. |
SANGER |
SK-NEP-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SK-NEP-1 cell growth in a cell viability assay, IC50 = 2.044 μM. |
SANGER |
LOXIMVI |
Growth Inhibition Assay |
|
|
|
Inhibition of human LOXIMVI cell growth in a cell viability assay, IC50 = 2.04434 μM. |
SANGER |
QIMR-WIL |
Growth Inhibition Assay |
|
|
|
Inhibition of human QIMR-WIL cell growth in a cell viability assay, IC50 = 2.07849 μM. |
SANGER |
DU-145 |
Growth Inhibition Assay |
|
|
|
Inhibition of human DU-145 cell growth in a cell viability assay, IC50 = 2.11056 μM. |
SANGER |
NB14 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NB14 cell growth in a cell viability assay, IC50 = 2.11321 μM. |
SANGER |
G-361 |
Growth Inhibition Assay |
|
|
|
Inhibition of human G-361 cell growth in a cell viability assay, IC50 = 2.1221 μM. |
SANGER |
BPH-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human BPH-1 cell growth in a cell viability assay, IC50 = 2.12957 μM. |
SANGER |
KYSE-150 |
Growth Inhibition Assay |
|
|
|
Inhibition of human KYSE-150 cell growth in a cell viability assay, IC50 = 2.15234 μM. |
SANGER |
HMV-II |
Growth Inhibition Assay |
|
|
|
Inhibition of human HMV-II cell growth in a cell viability assay, IC50 = 2.16633 μM. |
SANGER |
TE-9 |
Growth Inhibition Assay |
|
|
|
Inhibition of human TE-9 cell growth in a cell viability assay, IC50 = 2.17376 μM. |
SANGER |
8-MG-BA |
Growth Inhibition Assay |
|
|
|
Inhibition of human 8-MG-BA cell growth in a cell viability assay, IC50 = 2.23461 μM. |
SANGER |
ES5 |
Growth Inhibition Assay |
|
|
|
Inhibition of human ES5 cell growth in a cell viability assay, IC50 = 2.23633 μM. |
SANGER |
D-283MED |
Growth Inhibition Assay |
|
|
|
Inhibition of human D-283MED cell growth in a cell viability assay, IC50 = 2.23695 μM. |
SANGER |
SK-N-AS |
Growth Inhibition Assay |
|
|
|
Inhibition of human SK-N-AS cell growth in a cell viability assay, IC50 = 2.29059 μM. |
SANGER |
SW1710 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SW1710 cell growth in a cell viability assay, IC50 = 2.30661 μM. |
SANGER |
GCT |
Growth Inhibition Assay |
|
|
|
Inhibition of human GCT cell growth in a cell viability assay, IC50 = 2.31358 μM. |
SANGER |
AGS |
Growth Inhibition Assay |
|
|
|
Inhibition of human AGS cell growth in a cell viability assay, IC50 = 2.34404 μM. |
SANGER |
HuO9 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HuO9 cell growth in a cell viability assay, IC50 = 2.36824 μM. |
SANGER |
MN-60 |
Growth Inhibition Assay |
|
|
|
Inhibition of human MN-60 cell growth in a cell viability assay, IC50 = 2.44883 μM. |
SANGER |
NB6 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NB6 cell growth in a cell viability assay, IC50 = 2.45779 μM. |
SANGER |
NCI-H1395 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H1395 cell growth in a cell viability assay, IC50 = 2.47121 μM. |
SANGER |
H4 |
Growth Inhibition Assay |
|
|
|
Inhibition of human H4 cell growth in a cell viability assay, IC50 = 2.48393 μM. |
SANGER |
HT-3 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HT-3 cell growth in a cell viability assay, IC50 = 2.51024 μM. |
SANGER |
P12-ICHIKAWA |
Growth Inhibition Assay |
|
|
|
Inhibition of human P12-ICHIKAWA cell growth in a cell viability assay, IC50 = 2.52559 μM. |
SANGER |
COLO-800 |
Growth Inhibition Assay |
|
|
|
Inhibition of human COLO-800 cell growth in a cell viability assay, IC50 = 2.54166 μM. |
SANGER |
DB |
Growth Inhibition Assay |
|
|
|
Inhibition of human DB cell growth in a cell viability assay, IC50 = 2.55013 μM. |
SANGER |
LCLC-97TM1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human LCLC-97TM1 cell growth in a cell viability assay, IC50 = 2.60028 μM. |
SANGER |
Ca9-22 |
Growth Inhibition Assay |
|
|
|
Inhibition of human Ca9-22 cell growth in a cell viability assay, IC50 = 2.65933 μM. |
SANGER |
Becker |
Growth Inhibition Assay |
|
|
|
Inhibition of human Becker cell growth in a cell viability assay, IC50 = 2.66078 μM. |
SANGER |
ACN |
Growth Inhibition Assay |
|
|
|
Inhibition of human ACN cell growth in a cell viability assay, IC50 = 2.6679 μM. |
SANGER |
SJSA-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SJSA-1 cell growth in a cell viability assay, IC50 = 2.6687 μM. |
SANGER |
NCI-H1048 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H1048 cell growth in a cell viability assay, IC50 = 2.68321 μM. |
SANGER |
HEL |
Growth Inhibition Assay |
|
|
|
Inhibition of human HEL cell growth in a cell viability assay, IC50 = 2.70254 μM. |
SANGER |
NCI-H69 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H69 cell growth in a cell viability assay, IC50 = 2.71601 μM. |
SANGER |
639-V |
Growth Inhibition Assay |
|
|
|
Inhibition of human 639-V cell growth in a cell viability assay, IC50 = 2.71703 μM. |
SANGER |
U251 |
Growth Inhibition Assay |
|
|
|
Inhibition of human U251 cell growth in a cell viability assay, IC50 = 2.73032 μM. |
SANGER |
NCI-H1792 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H1792 cell growth in a cell viability assay, IC50 = 2.73738 μM. |
SANGER |
EW-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human EW-1 cell growth in a cell viability assay, IC50 = 2.75328 μM. |
SANGER |
ME-180 |
Growth Inhibition Assay |
|
|
|
Inhibition of human ME-180 cell growth in a cell viability assay, IC50 = 2.77736 μM. |
SANGER |
HH |
Growth Inhibition Assay |
|
|
|
Inhibition of human HH cell growth in a cell viability assay, IC50 = 2.80001 μM. |
SANGER |
SW954 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SW954 cell growth in a cell viability assay, IC50 = 2.8583 μM. |
SANGER |
SF268 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SF268 cell growth in a cell viability assay, IC50 = 2.87225 μM. |
SANGER |
D-566MG |
Growth Inhibition Assay |
|
|
|
Inhibition of human D-566MG cell growth in a cell viability assay, IC50 = 2.91295 μM. |
SANGER |
EM-2 |
Growth Inhibition Assay |
|
|
|
Inhibition of human EM-2 cell growth in a cell viability assay, IC50 = 2.92193 μM. |
SANGER |
NCI-H1299 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H1299 cell growth in a cell viability assay, IC50 = 2.93736 μM. |
SANGER |
PSN1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human PSN1 cell growth in a cell viability assay, IC50 = 3.05786 μM. |
SANGER |
JVM-3 |
Growth Inhibition Assay |
|
|
|
Inhibition of human JVM-3 cell growth in a cell viability assay, IC50 = 3.06756 μM. |
SANGER |
D-502MG |
Growth Inhibition Assay |
|
|
|
Inhibition of human D-502MG cell growth in a cell viability assay, IC50 = 3.07019 μM. |
SANGER |
SCC-4 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SCC-4 cell growth in a cell viability assay, IC50 = 3.09276 μM. |
SANGER |
GMS-10 |
Growth Inhibition Assay |
|
|
|
Inhibition of human GMS-10 cell growth in a cell viability assay, IC50 = 3.09388 μM. |
SANGER |
A427 |
Growth Inhibition Assay |
|
|
|
Inhibition of human A427 cell growth in a cell viability assay, IC50 = 3.10873 μM. |
SANGER |
NH-12 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NH-12 cell growth in a cell viability assay, IC50 = 3.11456 μM. |
SANGER |
KM12 |
Growth Inhibition Assay |
|
|
|
Inhibition of human KM12 cell growth in a cell viability assay, IC50 = 3.12273 μM. |
SANGER |
GI-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human GI-1 cell growth in a cell viability assay, IC50 = 3.15255 μM. |
SANGER |
TE-8 |
Growth Inhibition Assay |
|
|
|
Inhibition of human TE-8 cell growth in a cell viability assay, IC50 = 3.19231 μM. |
SANGER |
MKN1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human MKN1 cell growth in a cell viability assay, IC50 = 3.20875 μM. |
SANGER |
NCI-H810 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H810 cell growth in a cell viability assay, IC50 = 3.22155 μM. |
SANGER |
GOTO |
Growth Inhibition Assay |
|
|
|
Inhibition of human GOTO cell growth in a cell viability assay, IC50 = 3.28004 μM. |
SANGER |
T98G |
Growth Inhibition Assay |
|
|
|
Inhibition of human T98G cell growth in a cell viability assay, IC50 = 3.28216 μM. |
SANGER |
HD-MY-Z |
Growth Inhibition Assay |
|
|
|
Inhibition of human HD-MY-Z cell growth in a cell viability assay, IC50 = 3.36542 μM. |
SANGER |
SNU-C2B |
Growth Inhibition Assay |
|
|
|
Inhibition of human SNU-C2B cell growth in a cell viability assay, IC50 = 3.39097 μM. |
SANGER |
MOLT-4 |
Growth Inhibition Assay |
|
|
|
Inhibition of human MOLT-4 cell growth in a cell viability assay, IC50 = 3.39098 μM. |
SANGER |
RPMI-7951 |
Growth Inhibition Assay |
|
|
|
Inhibition of human RPMI-7951 cell growth in a cell viability assay, IC50 = 3.3973 μM. |
SANGER |
EW-11 |
Growth Inhibition Assay |
|
|
|
Inhibition of human EW-11 cell growth in a cell viability assay, IC50 = 3.41224 μM. |
SANGER |
RD |
Growth Inhibition Assay |
|
|
|
Inhibition of human RD cell growth in a cell viability assay, IC50 = 3.43132 μM. |
SANGER |
SW48 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SW48 cell growth in a cell viability assay, IC50 = 3.43358 μM. |
SANGER |
BB65-RCC |
Growth Inhibition Assay |
|
|
|
Inhibition of human BB65-RCC cell growth in a cell viability assay, IC50 = 3.45396 μM. |
SANGER |
Ca-Ski |
Growth Inhibition Assay |
|
|
|
Inhibition of human Ca-Ski cell growth in a cell viability assay, IC50 = 3.47514 μM. |
SANGER |
CHP-134 |
Growth Inhibition Assay |
|
|
|
Inhibition of human CHP-134 cell growth in a cell viability assay, IC50 = 3.48758 μM. |
SANGER |
CAL-33 |
Growth Inhibition Assay |
|
|
|
Inhibition of human CAL-33 cell growth in a cell viability assay, IC50 = 3.53362 μM. |
SANGER |
TYK-nu |
Growth Inhibition Assay |
|
|
|
Inhibition of human TYK-nu cell growth in a cell viability assay, IC50 = 3.53676 μM. |
SANGER |
LB831-BLC |
Growth Inhibition Assay |
|
|
|
Inhibition of human LB831-BLC cell growth in a cell viability assay, IC50 = 3.54016 μM. |
SANGER |
KU-19-19 |
Growth Inhibition Assay |
|
|
|
Inhibition of human KU-19-19 cell growth in a cell viability assay, IC50 = 3.60304 μM. |
SANGER |
KG-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human KG-1 cell growth in a cell viability assay, IC50 = 3.61106 μM. |
SANGER |
COLO-829 |
Growth Inhibition Assay |
|
|
|
Inhibition of human COLO-829 cell growth in a cell viability assay, IC50 = 3.66618 μM. |
SANGER |
HUTU-80 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HUTU-80 cell growth in a cell viability assay, IC50 = 3.66621 μM. |
SANGER |
NCI-H446 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H446 cell growth in a cell viability assay, IC50 = 3.6834 μM. |
SANGER |
LB2241-RCC |
Growth Inhibition Assay |
|
|
|
Inhibition of human LB2241-RCC cell growth in a cell viability assay, IC50 = 3.68625 μM. |
SANGER |
JEG-3 |
Growth Inhibition Assay |
|
|
|
Inhibition of human JEG-3 cell growth in a cell viability assay, IC50 = 3.6919 μM. |
SANGER |
LNCaP-Clone-FGC |
Growth Inhibition Assay |
|
|
|
Inhibition of human LNCaP-Clone-FGC cell growth in a cell viability assay, IC50 = 3.70041 μM. |
SANGER |
M059J |
Growth Inhibition Assay |
|
|
|
Inhibition of human M059J cell growth in a cell viability assay, IC50 = 3.71468 μM. |
SANGER |
SK-MES-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SK-MES-1 cell growth in a cell viability assay, IC50 = 3.7303 μM. |
SANGER |
GT3TKB |
Growth Inhibition Assay |
|
|
|
Inhibition of human GT3TKB cell growth in a cell viability assay, IC50 = 3.75604 μM. |
SANGER |
DOK |
Growth Inhibition Assay |
|
|
|
Inhibition of human DOK cell growth in a cell viability assay, IC50 = 3.76526 μM. |
SANGER |
HO-1-N-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HO-1-N-1 cell growth in a cell viability assay, IC50 = 3.79801 μM. |
SANGER |
MZ1-PC |
Growth Inhibition Assay |
|
|
|
Inhibition of human MZ1-PC cell growth in a cell viability assay, IC50 = 3.82883 μM. |
SANGER |
8305C |
Growth Inhibition Assay |
|
|
|
Inhibition of human 8305C cell growth in a cell viability assay, IC50 = 3.88943 μM. |
SANGER |
CGTH-W-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human CGTH-W-1 cell growth in a cell viability assay, IC50 = 3.93504 μM. |
SANGER |
LU-134-A |
Growth Inhibition Assay |
|
|
|
Inhibition of human LU-134-A cell growth in a cell viability assay, IC50 = 3.95422 μM. |
SANGER |
C32 |
Growth Inhibition Assay |
|
|
|
Inhibition of human C32 cell growth in a cell viability assay, IC50 = 3.96581 μM. |
SANGER |
MOLT-13 |
Growth Inhibition Assay |
|
|
|
Inhibition of human MOLT-13 cell growth in a cell viability assay, IC50 = 3.96856 μM. |
SANGER |
A375 |
Growth Inhibition Assay |
|
|
|
Inhibition of human A375 cell growth in a cell viability assay, IC50 = 4.05162 μM. |
SANGER |
CAL-12T |
Growth Inhibition Assay |
|
|
|
Inhibition of human CAL-12T cell growth in a cell viability assay, IC50 = 4.05795 μM. |
SANGER |
IGR-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human IGR-1 cell growth in a cell viability assay, IC50 = 4.10274 μM. |
SANGER |
LB1047-RCC |
Growth Inhibition Assay |
|
|
|
Inhibition of human LB1047-RCC cell growth in a cell viability assay, IC50 = 4.10441 μM. |
SANGER |
BHT-101 |
Growth Inhibition Assay |
|
|
|
Inhibition of human BHT-101 cell growth in a cell viability assay, IC50 = 4.10683 μM. |
SANGER |
A431 |
Growth Inhibition Assay |
|
|
|
Inhibition of human A431 cell growth in a cell viability assay, IC50 = 4.14081 μM. |
SANGER |
EPLC-272H |
Growth Inhibition Assay |
|
|
|
Inhibition of human EPLC-272H cell growth in a cell viability assay, IC50 = 4.17596 μM. |
SANGER |
HT-1376 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HT-1376 cell growth in a cell viability assay, IC50 = 4.23059 μM. |
SANGER |
HCC1954 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HCC1954 cell growth in a cell viability assay, IC50 = 4.25746 μM. |
SANGER |
KYSE-510 |
Growth Inhibition Assay |
|
|
|
Inhibition of human KYSE-510 cell growth in a cell viability assay, IC50 = 4.2609 μM. |
SANGER |
PANC-03-27 |
Growth Inhibition Assay |
|
|
|
Inhibition of human PANC-03-27 cell growth in a cell viability assay, IC50 = 4.30083 μM. |
SANGER |
MDA-MB-157 |
Growth Inhibition Assay |
|
|
|
Inhibition of human MDA-MB-157 cell growth in a cell viability assay, IC50 = 4.30656 μM. |
SANGER |
HOP-62 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HOP-62 cell growth in a cell viability assay, IC50 = 4.30856 μM. |
SANGER |
ETK-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human ETK-1 cell growth in a cell viability assay, IC50 = 4.36203 μM. |
SANGER |
MIA-PaCa-2 |
Growth Inhibition Assay |
|
|
|
Inhibition of human MIA-PaCa-2 cell growth in a cell viability assay, IC50 = 4.36227 μM. |
SANGER |
MHH-PREB-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human MHH-PREB-1 cell growth in a cell viability assay, IC50 = 4.39773 μM. |
SANGER |
LXF-289 |
Growth Inhibition Assay |
|
|
|
Inhibition of human LXF-289 cell growth in a cell viability assay, IC50 = 4.40202 μM. |
SANGER |
ATN-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human ATN-1 cell growth in a cell viability assay, IC50 = 4.42341 μM. |
SANGER |
8505C |
Growth Inhibition Assay |
|
|
|
Inhibition of human 8505C cell growth in a cell viability assay, IC50 = 4.45825 μM. |
SANGER |
HOS |
Growth Inhibition Assay |
|
|
|
Inhibition of human HOS cell growth in a cell viability assay, IC50 = 4.46453 μM. |
SANGER |
U-266 |
Growth Inhibition Assay |
|
|
|
Inhibition of human U-266 cell growth in a cell viability assay, IC50 = 4.61032 μM. |
SANGER |
5637 |
Growth Inhibition Assay |
|
|
|
Inhibition of human 5637 cell growth in a cell viability assay, IC50 = 4.61444 μM. |
SANGER |
GCIY |
Growth Inhibition Assay |
|
|
|
Inhibition of human GCIY cell growth in a cell viability assay, IC50 = 4.71015 μM. |
SANGER |
MDA-MB-231 |
Growth Inhibition Assay |
|
|
|
Inhibition of human MDA-MB-231 cell growth in a cell viability assay, IC50 = 4.72115 μM. |
SANGER |
RKO |
Growth Inhibition Assay |
|
|
|
Inhibition of human RKO cell growth in a cell viability assay, IC50 = 4.72817 μM. |
SANGER |
COR-L23 |
Growth Inhibition Assay |
|
|
|
Inhibition of human COR-L23 cell growth in a cell viability assay, IC50 = 4.74256 μM. |
SANGER |
DJM-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human DJM-1 cell growth in a cell viability assay, IC50 = 4.79729 μM. |
SANGER |
D-423MG |
Growth Inhibition Assay |
|
|
|
Inhibition of human D-423MG cell growth in a cell viability assay, IC50 = 4.80803 μM. |
SANGER |
DMS-114 |
Growth Inhibition Assay |
|
|
|
Inhibition of human DMS-114 cell growth in a cell viability assay, IC50 = 4.81386 μM. |
SANGER |
MHH-ES-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human MHH-ES-1 cell growth in a cell viability assay, IC50 = 4.82504 μM. |
SANGER |
CAL-51 |
Growth Inhibition Assay |
|
|
|
Inhibition of human CAL-51 cell growth in a cell viability assay, IC50 = 4.86843 μM. |
SANGER |
SW626 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SW626 cell growth in a cell viability assay, IC50 = 4.89697 μM. |
SANGER |
COLO-824 |
Growth Inhibition Assay |
|
|
|
Inhibition of human COLO-824 cell growth in a cell viability assay, IC50 = 4.90408 μM. |
SANGER |
NCI-H1437 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H1437 cell growth in a cell viability assay, IC50 = 4.9293 μM. |
SANGER |
CAL-39 |
Growth Inhibition Assay |
|
|
|
Inhibition of human CAL-39 cell growth in a cell viability assay, IC50 = 4.93988 μM. |
SANGER |
PC-3 |
Growth Inhibition Assay |
|
|
|
Inhibition of human PC-3 cell growth in a cell viability assay, IC50 = 4.94648 μM. |
SANGER |
A101D |
Growth Inhibition Assay |
|
|
|
Inhibition of human A101D cell growth in a cell viability assay, IC50 = 4.96865 μM. |
SANGER |
ES1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human ES1 cell growth in a cell viability assay, IC50 = 5.0013 μM. |
SANGER |
TE-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human TE-1 cell growth in a cell viability assay, IC50 = 5.03666 μM. |
SANGER |
KP-N-YN |
Growth Inhibition Assay |
|
|
|
Inhibition of human KP-N-YN cell growth in a cell viability assay, IC50 = 5.0567 μM. |
SANGER |
EFO-27 |
Growth Inhibition Assay |
|
|
|
Inhibition of human EFO-27 cell growth in a cell viability assay, IC50 = 5.06329 μM. |
SANGER |
BT-549 |
Growth Inhibition Assay |
|
|
|
Inhibition of human BT-549 cell growth in a cell viability assay, IC50 = 5.07736 μM. |
SANGER |
HLE |
Growth Inhibition Assay |
|
|
|
Inhibition of human HLE cell growth in a cell viability assay, IC50 = 5.11734 μM. |
SANGER |
SW982 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SW982 cell growth in a cell viability assay, IC50 = 5.13374 μM. |
SANGER |
SCC-25 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SCC-25 cell growth in a cell viability assay, IC50 = 5.19046 μM. |
SANGER |
SK-MEL-28 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SK-MEL-28 cell growth in a cell viability assay, IC50 = 5.20313 μM. |
SANGER |
CaR-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human CaR-1 cell growth in a cell viability assay, IC50 = 5.20726 μM. |
SANGER |
MLMA |
Growth Inhibition Assay |
|
|
|
Inhibition of human MLMA cell growth in a cell viability assay, IC50 = 5.23436 μM. |
SANGER |
VM-CUB-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human VM-CUB-1 cell growth in a cell viability assay, IC50 = 5.23439 μM. |
SANGER |
KNS-42 |
Growth Inhibition Assay |
|
|
|
Inhibition of human KNS-42 cell growth in a cell viability assay, IC50 = 5.2616 μM. |
SANGER |
TK10 |
Growth Inhibition Assay |
|
|
|
Inhibition of human TK10 cell growth in a cell viability assay, IC50 = 5.36086 μM. |
SANGER |
MEG-01 |
Growth Inhibition Assay |
|
|
|
Inhibition of human MEG-01 cell growth in a cell viability assay, IC50 = 5.36274 μM. |
SANGER |
DEL |
Growth Inhibition Assay |
|
|
|
Inhibition of human DEL cell growth in a cell viability assay, IC50 = 5.39023 μM. |
SANGER |
SJRH30 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SJRH30 cell growth in a cell viability assay, IC50 = 5.39213 μM. |
SANGER |
SK-PN-DW |
Growth Inhibition Assay |
|
|
|
Inhibition of human SK-PN-DW cell growth in a cell viability assay, IC50 = 5.43589 μM. |
SANGER |
TE-10 |
Growth Inhibition Assay |
|
|
|
Inhibition of human TE-10 cell growth in a cell viability assay, IC50 = 5.44893 μM. |
SANGER |
KNS-81-FD |
Growth Inhibition Assay |
|
|
|
Inhibition of human KNS-81-FD cell growth in a cell viability assay, IC50 = 5.50092 μM. |
SANGER |
BHY |
Growth Inhibition Assay |
|
|
|
Inhibition of human BHY cell growth in a cell viability assay, IC50 = 5.5107 μM. |
SANGER |
KYSE-270 |
Growth Inhibition Assay |
|
|
|
Inhibition of human KYSE-270 cell growth in a cell viability assay, IC50 = 5.53536 μM. |
SANGER |
NCI-H650 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H650 cell growth in a cell viability assay, IC50 = 5.57114 μM. |
SANGER |
L-363 |
Growth Inhibition Assay |
|
|
|
Inhibition of human L-363 cell growth in a cell viability assay, IC50 = 5.69476 μM. |
SANGER |
TCCSUP |
Growth Inhibition Assay |
|
|
|
Inhibition of human TCCSUP cell growth in a cell viability assay, IC50 = 5.71778 μM. |
SANGER |
SCH |
Growth Inhibition Assay |
|
|
|
Inhibition of human SCH cell growth in a cell viability assay, IC50 = 5.74767 μM. |
SANGER |
HTC-C3 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HTC-C3 cell growth in a cell viability assay, IC50 = 5.77644 μM. |
SANGER |
J-RT3-T3-5 |
Growth Inhibition Assay |
|
|
|
Inhibition of human J-RT3-T3-5 cell growth in a cell viability assay, IC50 = 5.80794 μM. |
SANGER |
Hs-578-T |
Growth Inhibition Assay |
|
|
|
Inhibition of human Hs-578-T cell growth in a cell viability assay, IC50 = 5.83607 μM. |
SANGER |
M14 |
Growth Inhibition Assay |
|
|
|
Inhibition of human M14 cell growth in a cell viability assay, IC50 = 5.86726 μM. |
SANGER |
HT-144 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HT-144 cell growth in a cell viability assay, IC50 = 5.86832 μM. |
SANGER |
CAL-54 |
Growth Inhibition Assay |
|
|
|
Inhibition of human CAL-54 cell growth in a cell viability assay, IC50 = 5.93314 μM. |
SANGER |
T47D |
Growth Inhibition Assay |
|
|
|
Inhibition of human T47D cell growth in a cell viability assay, IC50 = 5.9612 μM. |
SANGER |
GB-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human GB-1 cell growth in a cell viability assay, IC50 = 6.02068 μM. |
SANGER |
HSC-2 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HSC-2 cell growth in a cell viability assay, IC50 = 6.12353 μM. |
SANGER |
SiHa |
Growth Inhibition Assay |
|
|
|
Inhibition of human SiHa cell growth in a cell viability assay, IC50 = 6.14097 μM. |
SANGER |
OMC-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human OMC-1 cell growth in a cell viability assay, IC50 = 6.35441 μM. |
SANGER |
HGC-27 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HGC-27 cell growth in a cell viability assay, IC50 = 6.35786 μM. |
SANGER |
FTC-133 |
Growth Inhibition Assay |
|
|
|
Inhibition of human FTC-133 cell growth in a cell viability assay, IC50 = 6.46551 μM. |
SANGER |
KS-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human KS-1 cell growth in a cell viability assay, IC50 = 6.52147 μM. |
SANGER |
HT-1080 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HT-1080 cell growth in a cell viability assay, IC50 = 6.54042 μM. |
SANGER |
SKG-IIIa |
Growth Inhibition Assay |
|
|
|
Inhibition of human SKG-IIIa cell growth in a cell viability assay, IC50 = 6.56263 μM. |
SANGER |
OCUB-M |
Growth Inhibition Assay |
|
|
|
Inhibition of human OCUB-M cell growth in a cell viability assay, IC50 = 6.6077 μM. |
SANGER |
MDA-MB-175-VII |
Growth Inhibition Assay |
|
|
|
Inhibition of human MDA-MB-175-VII cell growth in a cell viability assay, IC50 = 6.6209 μM. |
SANGER |
BB30-HNC |
Growth Inhibition Assay |
|
|
|
Inhibition of human BB30-HNC cell growth in a cell viability assay, IC50 = 6.67444 μM. |
SANGER |
D-542MG |
Growth Inhibition Assay |
|
|
|
Inhibition of human D-542MG cell growth in a cell viability assay, IC50 = 6.7309 μM. |
SANGER |
NCI-H2405 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H2405 cell growth in a cell viability assay, IC50 = 6.74855 μM. |
SANGER |
SW1573 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SW1573 cell growth in a cell viability assay, IC50 = 6.78319 μM. |
SANGER |
NCI-SNU-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-SNU-1 cell growth in a cell viability assay, IC50 = 6.79022 μM. |
SANGER |
RT-112 |
Growth Inhibition Assay |
|
|
|
Inhibition of human RT-112 cell growth in a cell viability assay, IC50 = 6.79463 μM. |
SANGER |
COR-L88 |
Growth Inhibition Assay |
|
|
|
Inhibition of human COR-L88 cell growth in a cell viability assay, IC50 = 6.79791 μM. |
SANGER |
SCC-9 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SCC-9 cell growth in a cell viability assay, IC50 = 6.8255 μM. |
SANGER |
U-87-MG |
Growth Inhibition Assay |
|
|
|
Inhibition of human U-87-MG cell growth in a cell viability assay, IC50 = 6.83826 μM. |
SANGER |
Detroit562 |
Growth Inhibition Assay |
|
|
|
Inhibition of human Detroit562 cell growth in a cell viability assay, IC50 = 6.85991 μM. |
SANGER |
LC-2-ad |
Growth Inhibition Assay |
|
|
|
Inhibition of human LC-2-ad cell growth in a cell viability assay, IC50 = 6.86292 μM. |
SANGER |
IGROV-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human IGROV-1 cell growth in a cell viability assay, IC50 = 6.92583 μM. |
SANGER |
OVCAR-8 |
Growth Inhibition Assay |
|
|
|
Inhibition of human OVCAR-8 cell growth in a cell viability assay, IC50 = 6.94229 μM. |
SANGER |
SNU-387 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SNU-387 cell growth in a cell viability assay, IC50 = 6.99516 μM. |
SANGER |
TGBC1TKB |
Growth Inhibition Assay |
|
|
|
Inhibition of human TGBC1TKB cell growth in a cell viability assay, IC50 = 7.15277 μM. |
SANGER |
NOS-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NOS-1 cell growth in a cell viability assay, IC50 = 7.20415 μM. |
SANGER |
HEC-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HEC-1 cell growth in a cell viability assay, IC50 = 7.25387 μM. |
SANGER |
GI-ME-N |
Growth Inhibition Assay |
|
|
|
Inhibition of human GI-ME-N cell growth in a cell viability assay, IC50 = 7.29158 μM. |
SANGER |
KYSE-520 |
Growth Inhibition Assay |
|
|
|
Inhibition of human KYSE-520 cell growth in a cell viability assay, IC50 = 7.2929 μM. |
SANGER |
SNU-423 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SNU-423 cell growth in a cell viability assay, IC50 = 7.29452 μM. |
SANGER |
C-33-A |
Growth Inhibition Assay |
|
|
|
Inhibition of human C-33-A cell growth in a cell viability assay, IC50 = 7.4782 μM. |
SANGER |
SK-UT-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SK-UT-1 cell growth in a cell viability assay, IC50 = 7.54829 μM. |
SANGER |
OVCAR-4 |
Growth Inhibition Assay |
|
|
|
Inhibition of human OVCAR-4 cell growth in a cell viability assay, IC50 = 7.5526 μM. |
SANGER |
KYSE-450 |
Growth Inhibition Assay |
|
|
|
Inhibition of human KYSE-450 cell growth in a cell viability assay, IC50 = 7.63791 μM. |
SANGER |
RS4-11 |
Growth Inhibition Assay |
|
|
|
Inhibition of human RS4-11 cell growth in a cell viability assay, IC50 = 7.70196 μM. |
SANGER |
OVCAR-5 |
Growth Inhibition Assay |
|
|
|
Inhibition of human OVCAR-5 cell growth in a cell viability assay, IC50 = 7.82329 μM. |
SANGER |
K5 |
Growth Inhibition Assay |
|
|
|
Inhibition of human K5 cell growth in a cell viability assay, IC50 = 7.8742 μM. |
SANGER |
786-0 |
Growth Inhibition Assay |
|
|
|
Inhibition of human 786-0 cell growth in a cell viability assay, IC50 = 8.03095 μM. |
SANGER |
NCI-H747 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H747 cell growth in a cell viability assay, IC50 = 8.04457 μM. |
SANGER |
CAL-27 |
Growth Inhibition Assay |
|
|
|
Inhibition of human CAL-27 cell growth in a cell viability assay, IC50 = 8.1272 μM. |
SANGER |
FADU |
Growth Inhibition Assay |
|
|
|
Inhibition of human FADU cell growth in a cell viability assay, IC50 = 8.17543 μM. |
SANGER |
SW780 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SW780 cell growth in a cell viability assay, IC50 = 8.18821 μM. |
SANGER |
ACHN |
Growth Inhibition Assay |
|
|
|
Inhibition of human ACHN cell growth in a cell viability assay, IC50 = 8.22529 μM. |
SANGER |
TE-6 |
Growth Inhibition Assay |
|
|
|
Inhibition of human TE-6 cell growth in a cell viability assay, IC50 = 8.23788 μM. |
SANGER |
NCI-H2087 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H2087 cell growth in a cell viability assay, IC50 = 8.36158 μM. |
SANGER |
NCI-H2122 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H2122 cell growth in a cell viability assay, IC50 = 8.40479 μM. |
SANGER |
SK-LU-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SK-LU-1 cell growth in a cell viability assay, IC50 = 8.43997 μM. |
SANGER |
22RV1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human 22RV1 cell growth in a cell viability assay, IC50 = 8.61786 μM. |
SANGER |
MEL-JUSO |
Growth Inhibition Assay |
|
|
|
Inhibition of human MEL-JUSO cell growth in a cell viability assay, IC50 = 8.68675 μM. |
SANGER |
UM-UC-3 |
Growth Inhibition Assay |
|
|
|
Inhibition of human UM-UC-3 cell growth in a cell viability assay, IC50 = 8.7139 μM. |
SANGER |
HuH-7 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HuH-7 cell growth in a cell viability assay, IC50 = 8.73012 μM. |
SANGER |
SNU-449 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SNU-449 cell growth in a cell viability assay, IC50 = 8.75265 μM. |
SANGER |
RVH-421 |
Growth Inhibition Assay |
|
|
|
Inhibition of human RVH-421 cell growth in a cell viability assay, IC50 = 8.75398 μM. |
SANGER |
MFM-223 |
Growth Inhibition Assay |
|
|
|
Inhibition of human MFM-223 cell growth in a cell viability assay, IC50 = 8.80735 μM. |
SANGER |
CHP-212 |
Growth Inhibition Assay |
|
|
|
Inhibition of human CHP-212 cell growth in a cell viability assay, IC50 = 8.82267 μM. |
SANGER |
NCI-H28 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H28 cell growth in a cell viability assay, IC50 = 8.85185 μM. |
SANGER |
C8166 |
Growth Inhibition Assay |
|
|
|
Inhibition of human C8166 cell growth in a cell viability assay, IC50 = 8.86772 μM. |
SANGER |
SCC-15 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SCC-15 cell growth in a cell viability assay, IC50 = 8.87196 μM. |
SANGER |
DMS-273 |
Growth Inhibition Assay |
|
|
|
Inhibition of human DMS-273 cell growth in a cell viability assay, IC50 = 8.89623 μM. |
SANGER |
MPP-89 |
Growth Inhibition Assay |
|
|
|
Inhibition of human MPP-89 cell growth in a cell viability assay, IC50 = 8.91341 μM. |
SANGER |
EW-22 |
Growth Inhibition Assay |
|
|
|
Inhibition of human EW-22 cell growth in a cell viability assay, IC50 = 8.91382 μM. |
SANGER |
RCM-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human RCM-1 cell growth in a cell viability assay, IC50 = 8.96486 μM. |
SANGER |
BT-474 |
Growth Inhibition Assay |
|
|
|
Inhibition of human BT-474 cell growth in a cell viability assay, IC50 = 8.98872 μM. |
SANGER |
TI-73 |
Growth Inhibition Assay |
|
|
|
Inhibition of human TI-73 cell growth in a cell viability assay, IC50 = 9.03496 μM. |
SANGER |
ES3 |
Growth Inhibition Assay |
|
|
|
Inhibition of human ES3 cell growth in a cell viability assay, IC50 = 9.05156 μM. |
SANGER |
NB17 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NB17 cell growth in a cell viability assay, IC50 = 9.14535 μM. |
SANGER |
MOLT-16 |
Growth Inhibition Assay |
|
|
|
Inhibition of human MOLT-16 cell growth in a cell viability assay, IC50 = 9.16655 μM. |
SANGER |
TGBC11TKB |
Growth Inhibition Assay |
|
|
|
Inhibition of human TGBC11TKB cell growth in a cell viability assay, IC50 = 9.19205 μM. |
SANGER |
NB12 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NB12 cell growth in a cell viability assay, IC50 = 9.34081 μM. |
SANGER |
MEL-HO |
Growth Inhibition Assay |
|
|
|
Inhibition of human MEL-HO cell growth in a cell viability assay, IC50 = 9.402 μM. |
SANGER |
HuCCT1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HuCCT1 cell growth in a cell viability assay, IC50 = 9.47406 μM. |
SANGER |
A704 |
Growth Inhibition Assay |
|
|
|
Inhibition of human A704 cell growth in a cell viability assay, IC50 = 9.47745 μM. |
SANGER |
SW756 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SW756 cell growth in a cell viability assay, IC50 = 9.55361 μM. |
SANGER |
SAS |
Growth Inhibition Assay |
|
|
|
Inhibition of human SAS cell growth in a cell viability assay, IC50 = 9.58455 μM. |
SANGER |
KINGS-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human KINGS-1 cell growth in a cell viability assay, IC50 = 9.6937 μM. |
SANGER |
NKM-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NKM-1 cell growth in a cell viability assay, IC50 = 9.83964 μM. |
SANGER |
C2BBe1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human C2BBe1 cell growth in a cell viability assay, IC50 = 9.86204 μM. |
SANGER |
A204 |
Growth Inhibition Assay |
|
|
|
Inhibition of human A204 cell growth in a cell viability assay, IC50 = 9.89755 μM. |
SANGER |
G-401 |
Growth Inhibition Assay |
|
|
|
Inhibition of human G-401 cell growth in a cell viability assay, IC50 = 9.90449 μM. |
SANGER |
PFSK-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human PFSK-1 cell growth in a cell viability assay, IC50 = 9.95669 μM. |
SANGER |
KYSE-410 |
Growth Inhibition Assay |
|
|
|
Inhibition of human KYSE-410 cell growth in a cell viability assay, IC50 = 10.0615 μM. |
SANGER |
SK-MEL-2 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SK-MEL-2 cell growth in a cell viability assay, IC50 = 10.1588 μM. |
SANGER |
NB5 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NB5 cell growth in a cell viability assay, IC50 = 10.5405 μM. |
SANGER |
NTERA-S-cl-D1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NTERA-S-cl-D1 cell growth in a cell viability assay, IC50 = 10.5475 μM. |
SANGER |
MZ2-MEL |
Growth Inhibition Assay |
|
|
|
Inhibition of human MZ2-MEL cell growth in a cell viability assay, IC50 = 10.662 μM. |
SANGER |
SF539 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SF539 cell growth in a cell viability assay, IC50 = 10.7188 μM. |
SANGER |
CAL-120 |
Growth Inhibition Assay |
|
|
|
Inhibition of human CAL-120 cell growth in a cell viability assay, IC50 = 10.7597 μM. |
SANGER |
GR-ST |
Growth Inhibition Assay |
|
|
|
Inhibition of human GR-ST cell growth in a cell viability assay, IC50 = 11.298 μM. |
SANGER |
IA-LM |
Growth Inhibition Assay |
|
|
|
Inhibition of human IA-LM cell growth in a cell viability assay, IC50 = 11.3486 μM. |
SANGER |
NCI-H2452 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H2452 cell growth in a cell viability assay, IC50 = 11.3927 μM. |
SANGER |
NCI-H1648 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H1648 cell growth in a cell viability assay, IC50 = 11.4629 μM. |
SANGER |
YH-13 |
Growth Inhibition Assay |
|
|
|
Inhibition of human YH-13 cell growth in a cell viability assay, IC50 = 11.4742 μM. |
SANGER |
NCI-H2228 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H2228 cell growth in a cell viability assay, IC50 = 11.4928 μM. |
SANGER |
LN-405 |
Growth Inhibition Assay |
|
|
|
Inhibition of human LN-405 cell growth in a cell viability assay, IC50 = 11.5927 μM. |
SANGER |
647-V |
Growth Inhibition Assay |
|
|
|
Inhibition of human 647-V cell growth in a cell viability assay, IC50 = 11.5974 μM. |
SANGER |
HCC1806 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HCC1806 cell growth in a cell viability assay, IC50 = 11.6134 μM. |
SANGER |
HPAF-II |
Growth Inhibition Assay |
|
|
|
Inhibition of human HPAF-II cell growth in a cell viability assay, IC50 = 11.8356 μM. |
SANGER |
BB49-HNC |
Growth Inhibition Assay |
|
|
|
Inhibition of human BB49-HNC cell growth in a cell viability assay, IC50 = 11.8375 μM. |
SANGER |
KGN |
Growth Inhibition Assay |
|
|
|
Inhibition of human KGN cell growth in a cell viability assay, IC50 = 11.859 μM. |
SANGER |
NOMO-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NOMO-1 cell growth in a cell viability assay, IC50 = 11.8597 μM. |
SANGER |
A388 |
Growth Inhibition Assay |
|
|
|
Inhibition of human A388 cell growth in a cell viability assay, IC50 = 11.8808 μM. |
SANGER |
Saos-2 |
Growth Inhibition Assay |
|
|
|
Inhibition of human Saos-2 cell growth in a cell viability assay, IC50 = 12.2004 μM. |
SANGER |
SK-HEP-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SK-HEP-1 cell growth in a cell viability assay, IC50 = 12.2613 μM. |
SANGER |
HCE-4 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HCE-4 cell growth in a cell viability assay, IC50 = 12.27 μM. |
SANGER |
NCI-H1581 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H1581 cell growth in a cell viability assay, IC50 = 12.2819 μM. |
SANGER |
NCI-H23 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H23 cell growth in a cell viability assay, IC50 = 12.3125 μM. |
SANGER |
NCI-H596 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H596 cell growth in a cell viability assay, IC50 = 12.4798 μM. |
SANGER |
NB69 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NB69 cell growth in a cell viability assay, IC50 = 12.7585 μM. |
SANGER |
ChaGo-K-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human ChaGo-K-1 cell growth in a cell viability assay, IC50 = 12.7649 μM. |
SANGER |
EFM-19 |
Growth Inhibition Assay |
|
|
|
Inhibition of human EFM-19 cell growth in a cell viability assay, IC50 = 12.7717 μM. |
SANGER |
SW962 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SW962 cell growth in a cell viability assay, IC50 = 12.8223 μM. |
SANGER |
KALS-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human KALS-1 cell growth in a cell viability assay, IC50 = 13.095 μM. |
SANGER |
MDA-MB-415 |
Growth Inhibition Assay |
|
|
|
Inhibition of human MDA-MB-415 cell growth in a cell viability assay, IC50 = 13.1609 μM. |
SANGER |
SW684 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SW684 cell growth in a cell viability assay, IC50 = 13.1861 μM. |
SANGER |
NCI-H2052 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H2052 cell growth in a cell viability assay, IC50 = 13.3848 μM. |
SANGER |
HOP-92 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HOP-92 cell growth in a cell viability assay, IC50 = 13.7996 μM. |
SANGER |
OE19 |
Growth Inhibition Assay |
|
|
|
Inhibition of human OE19 cell growth in a cell viability assay, IC50 = 14.0075 μM. |
SANGER |
D-392MG |
Growth Inhibition Assay |
|
|
|
Inhibition of human D-392MG cell growth in a cell viability assay, IC50 = 14.1211 μM. |
SANGER |
A253 |
Growth Inhibition Assay |
|
|
|
Inhibition of human A253 cell growth in a cell viability assay, IC50 = 14.225 μM. |
SANGER |
NCI-H1155 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H1155 cell growth in a cell viability assay, IC50 = 14.2747 μM. |
SANGER |
SNB75 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SNB75 cell growth in a cell viability assay, IC50 = 14.3893 μM. |
SANGER |
23132-87 |
Growth Inhibition Assay |
|
|
|
Inhibition of human 23132-87 cell growth in a cell viability assay, IC50 = 14.8353 μM. |
SANGER |
Calu-3 |
Growth Inhibition Assay |
|
|
|
Inhibition of human Calu-3 cell growth in a cell viability assay, IC50 = 14.8743 μM. |
SANGER |
CW-2 |
Growth Inhibition Assay |
|
|
|
Inhibition of human CW-2 cell growth in a cell viability assay, IC50 = 15.0223 μM. |
SANGER |
COLO-679 |
Growth Inhibition Assay |
|
|
|
Inhibition of human COLO-679 cell growth in a cell viability assay, IC50 = 15.1013 μM. |
SANGER |
NCI-SNU-5 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-SNU-5 cell growth in a cell viability assay, IC50 = 15.5589 μM. |
SANGER |
AN3-CA |
Growth Inhibition Assay |
|
|
|
Inhibition of human AN3-CA cell growth in a cell viability assay, IC50 = 15.6468 μM. |
SANGER |
SF126 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SF126 cell growth in a cell viability assay, IC50 = 15.7285 μM. |
SANGER |
D-247MG |
Growth Inhibition Assay |
|
|
|
Inhibition of human D-247MG cell growth in a cell viability assay, IC50 = 15.8534 μM. |
SANGER |
UACC-62 |
Growth Inhibition Assay |
|
|
|
Inhibition of human UACC-62 cell growth in a cell viability assay, IC50 = 15.966 μM. |
SANGER |
GP5d |
Growth Inhibition Assay |
|
|
|
Inhibition of human GP5d cell growth in a cell viability assay, IC50 = 16.1171 μM. |
SANGER |
HuO-3N1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HuO-3N1 cell growth in a cell viability assay, IC50 = 16.2473 μM. |
SANGER |
NCI-H1092 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H1092 cell growth in a cell viability assay, IC50 = 16.6297 μM. |
SANGER |
HCC1187 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HCC1187 cell growth in a cell viability assay, IC50 = 16.6557 μM. |
SANGER |
G-402 |
Growth Inhibition Assay |
|
|
|
Inhibition of human G-402 cell growth in a cell viability assay, IC50 = 16.8565 μM. |
SANGER |
HT55 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HT55 cell growth in a cell viability assay, IC50 = 16.8751 μM. |
SANGER |
NCI-H2009 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H2009 cell growth in a cell viability assay, IC50 = 16.9266 μM. |
SANGER |
SH-4 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SH-4 cell growth in a cell viability assay, IC50 = 16.992 μM. |
SANGER |
SW1783 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SW1783 cell growth in a cell viability assay, IC50 = 16.9998 μM. |
SANGER |
HT |
Growth Inhibition Assay |
|
|
|
Inhibition of human HT cell growth in a cell viability assay, IC50 = 17.1964 μM. |
SANGER |
CP66-MEL |
Growth Inhibition Assay |
|
|
|
Inhibition of human CP66-MEL cell growth in a cell viability assay, IC50 = 17.301 μM. |
SANGER |
BEN |
Growth Inhibition Assay |
|
|
|
Inhibition of human BEN cell growth in a cell viability assay, IC50 = 17.5626 μM. |
SANGER |
HCC38 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HCC38 cell growth in a cell viability assay, IC50 = 17.7698 μM. |
SANGER |
LAN-6 |
Growth Inhibition Assay |
|
|
|
Inhibition of human LAN-6 cell growth in a cell viability assay, IC50 = 17.8485 μM. |
SANGER |
RERF-LC-MS |
Growth Inhibition Assay |
|
|
|
Inhibition of human RERF-LC-MS cell growth in a cell viability assay, IC50 = 17.9129 μM. |
SANGER |
NCI-H1770 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H1770 cell growth in a cell viability assay, IC50 = 17.9491 μM. |
SANGER |
LCLC-103H |
Growth Inhibition Assay |
|
|
|
Inhibition of human LCLC-103H cell growth in a cell viability assay, IC50 = 18.051 μM. |
SANGER |
NCI-H520 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H520 cell growth in a cell viability assay, IC50 = 18.3282 μM. |
SANGER |
LU-65 |
Growth Inhibition Assay |
|
|
|
Inhibition of human LU-65 cell growth in a cell viability assay, IC50 = 18.4043 μM. |
SANGER |
SK-MEL-3 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SK-MEL-3 cell growth in a cell viability assay, IC50 = 18.668 μM. |
SANGER |
LK-2 |
Growth Inhibition Assay |
|
|
|
Inhibition of human LK-2 cell growth in a cell viability assay, IC50 = 18.7723 μM. |
SANGER |
PANC-08-13 |
Growth Inhibition Assay |
|
|
|
Inhibition of human PANC-08-13 cell growth in a cell viability assay, IC50 = 18.7889 μM. |
SANGER |
NCI-H460 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H460 cell growth in a cell viability assay, IC50 = 18.8467 μM. |
SANGER |
COLO-684 |
Growth Inhibition Assay |
|
|
|
Inhibition of human COLO-684 cell growth in a cell viability assay, IC50 = 18.9956 μM. |
SANGER |
RPMI-2650 |
Growth Inhibition Assay |
|
|
|
Inhibition of human RPMI-2650 cell growth in a cell viability assay, IC50 = 19.012 μM. |
SANGER |
NY |
Growth Inhibition Assay |
|
|
|
Inhibition of human NY cell growth in a cell viability assay, IC50 = 19.1567 μM. |
SANGER |
NB7 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NB7 cell growth in a cell viability assay, IC50 = 19.1753 μM. |
SANGER |
NCI-H358 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H358 cell growth in a cell viability assay, IC50 = 19.2673 μM. |
SANGER |
MC116 |
Growth Inhibition Assay |
|
|
|
Inhibition of human MC116 cell growth in a cell viability assay, IC50 = 19.533 μM. |
SANGER |
MS-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human MS-1 cell growth in a cell viability assay, IC50 = 19.6103 μM. |
SANGER |
NCI-H82 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H82 cell growth in a cell viability assay, IC50 = 19.6878 μM. |
SANGER |
OCI-AML2 |
Growth Inhibition Assay |
|
|
|
Inhibition of human OCI-AML2 cell growth in a cell viability assay, IC50 = 19.7032 μM. |
SANGER |
LS-123 |
Growth Inhibition Assay |
|
|
|
Inhibition of human LS-123 cell growth in a cell viability assay, IC50 = 20.0194 μM. |
SANGER |
PC-14 |
Growth Inhibition Assay |
|
|
|
Inhibition of human PC-14 cell growth in a cell viability assay, IC50 = 20.1834 μM. |
SANGER |
NCI-H1703 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H1703 cell growth in a cell viability assay, IC50 = 20.8173 μM. |
SANGER |
Calu-6 |
Growth Inhibition Assay |
|
|
|
Inhibition of human Calu-6 cell growth in a cell viability assay, IC50 = 21.1005 μM. |
SANGER |
no-11 |
Growth Inhibition Assay |
|
|
|
Inhibition of human no-11 cell growth in a cell viability assay, IC50 = 21.1602 μM. |
SANGER |
NCI-H727 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H727 cell growth in a cell viability assay, IC50 = 21.3493 μM. |
SANGER |
DSH1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human DSH1 cell growth in a cell viability assay, IC50 = 21.3879 μM. |
SANGER |
KYSE-140 |
Growth Inhibition Assay |
|
|
|
Inhibition of human KYSE-140 cell growth in a cell viability assay, IC50 = 21.7271 μM. |
SANGER |
RH-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human RH-1 cell growth in a cell viability assay, IC50 = 21.883 μM. |
SANGER |
HAL-01 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HAL-01 cell growth in a cell viability assay, IC50 = 22.0419 μM. |
SANGER |
RXF393 |
Growth Inhibition Assay |
|
|
|
Inhibition of human RXF393 cell growth in a cell viability assay, IC50 = 22.2788 μM. |
SANGER |
LS-411N |
Growth Inhibition Assay |
|
|
|
Inhibition of human LS-411N cell growth in a cell viability assay, IC50 = 22.2869 μM. |
SANGER |
no-10 |
Growth Inhibition Assay |
|
|
|
Inhibition of human no-10 cell growth in a cell viability assay, IC50 = 22.5004 μM. |
SANGER |
MKN7 |
Growth Inhibition Assay |
|
|
|
Inhibition of human MKN7 cell growth in a cell viability assay, IC50 = 22.6869 μM. |
SANGER |
AU565 |
Growth Inhibition Assay |
|
|
|
Inhibition of human AU565 cell growth in a cell viability assay, IC50 = 22.7478 μM. |
SANGER |
NUGC-3 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NUGC-3 cell growth in a cell viability assay, IC50 = 23.1199 μM. |
SANGER |
EW-16 |
Growth Inhibition Assay |
|
|
|
Inhibition of human EW-16 cell growth in a cell viability assay, IC50 = 24.0926 μM. |
SANGER |
HCC70 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HCC70 cell growth in a cell viability assay, IC50 = 24.1323 μM. |
SANGER |
RPMI-8226 |
Growth Inhibition Assay |
|
|
|
Inhibition of human RPMI-8226 cell growth in a cell viability assay, IC50 = 24.3155 μM. |
SANGER |
CFPAC-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human CFPAC-1 cell growth in a cell viability assay, IC50 = 24.6272 μM. |
SANGER |
DoTc2-4510 |
Growth Inhibition Assay |
|
|
|
Inhibition of human DoTc2-4510 cell growth in a cell viability assay, IC50 = 24.7575 μM. |
SANGER |
KNS-62 |
Growth Inhibition Assay |
|
|
|
Inhibition of human KNS-62 cell growth in a cell viability assay, IC50 = 25.018 μM. |
SANGER |
SK-N-DZ |
Growth Inhibition Assay |
|
|
|
Inhibition of human SK-N-DZ cell growth in a cell viability assay, IC50 = 25.0904 μM. |
SANGER |
CAL-85-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human CAL-85-1 cell growth in a cell viability assay, IC50 = 25.1544 μM. |
SANGER |
JVM-2 |
Growth Inhibition Assay |
|
|
|
Inhibition of human JVM-2 cell growth in a cell viability assay, IC50 = 25.2122 μM. |
SANGER |
NCI-H2347 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H2347 cell growth in a cell viability assay, IC50 = 25.4248 μM. |
SANGER |
P30-OHK |
Growth Inhibition Assay |
|
|
|
Inhibition of human P30-OHK cell growth in a cell viability assay, IC50 = 25.6318 μM. |
SANGER |
SK-N-FI |
Growth Inhibition Assay |
|
|
|
Inhibition of human SK-N-FI cell growth in a cell viability assay, IC50 = 26.1162 μM. |
SANGER |
CAMA-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human CAMA-1 cell growth in a cell viability assay, IC50 = 26.4876 μM. |
SANGER |
MHH-NB-11 |
Growth Inhibition Assay |
|
|
|
Inhibition of human MHH-NB-11 cell growth in a cell viability assay, IC50 = 26.5851 μM. |
SANGER |
IST-MEL1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human IST-MEL1 cell growth in a cell viability assay, IC50 = 26.7177 μM. |
SANGER |
KARPAS-299 |
Growth Inhibition Assay |
|
|
|
Inhibition of human KARPAS-299 cell growth in a cell viability assay, IC50 = 27.4702 μM. |
SANGER |
TE-11 |
Growth Inhibition Assay |
|
|
|
Inhibition of human TE-11 cell growth in a cell viability assay, IC50 = 27.7342 μM. |
SANGER |
769-P |
Growth Inhibition Assay |
|
|
|
Inhibition of human 769-P cell growth in a cell viability assay, IC50 = 28.4533 μM. |
SANGER |
CAL-72 |
Growth Inhibition Assay |
|
|
|
Inhibition of human CAL-72 cell growth in a cell viability assay, IC50 = 28.5561 μM. |
SANGER |
NCI-H2342 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H2342 cell growth in a cell viability assay, IC50 = 29.3803 μM. |
SANGER |
NCI-H1651 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H1651 cell growth in a cell viability assay, IC50 = 29.8503 μM. |
SANGER |
OE33 |
Growth Inhibition Assay |
|
|
|
Inhibition of human OE33 cell growth in a cell viability assay, IC50 = 30.1342 μM. |
SANGER |
HuP-T4 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HuP-T4 cell growth in a cell viability assay, IC50 = 31.4837 μM. |
SANGER |
U-118-MG |
Growth Inhibition Assay |
|
|
|
Inhibition of human U-118-MG cell growth in a cell viability assay, IC50 = 32.5441 μM. |
SANGER |
SN12C |
Growth Inhibition Assay |
|
|
|
Inhibition of human SN12C cell growth in a cell viability assay, IC50 = 32.8815 μM. |
SANGER |
TE-5 |
Growth Inhibition Assay |
|
|
|
Inhibition of human TE-5 cell growth in a cell viability assay, IC50 = 33.1368 μM. |
SANGER |
KM-H2 |
Growth Inhibition Assay |
|
|
|
Inhibition of human KM-H2 cell growth in a cell viability assay, IC50 = 33.1699 μM. |
SANGER |
OVCAR-3 |
Growth Inhibition Assay |
|
|
|
Inhibition of human OVCAR-3 cell growth in a cell viability assay, IC50 = 33.4127 μM. |
SANGER |
NCI-H1304 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H1304 cell growth in a cell viability assay, IC50 = 33.6036 μM. |
SANGER |
LU-135 |
Growth Inhibition Assay |
|
|
|
Inhibition of human LU-135 cell growth in a cell viability assay, IC50 = 33.7086 μM. |
SANGER |
S-117 |
Growth Inhibition Assay |
|
|
|
Inhibition of human S-117 cell growth in a cell viability assay, IC50 = 33.7286 μM. |
SANGER |
NCI-H1755 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H1755 cell growth in a cell viability assay, IC50 = 33.811 μM. |
SANGER |
SK-OV-3 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SK-OV-3 cell growth in a cell viability assay, IC50 = 33.8854 μM. |
SANGER |
RCC10RGB |
Growth Inhibition Assay |
|
|
|
Inhibition of human RCC10RGB cell growth in a cell viability assay, IC50 = 33.9433 μM. |
SANGER |
COLO-680N |
Growth Inhibition Assay |
|
|
|
Inhibition of human COLO-680N cell growth in a cell viability assay, IC50 = 34.1397 μM. |
SANGER |
KURAMOCHI |
Growth Inhibition Assay |
|
|
|
Inhibition of human KURAMOCHI cell growth in a cell viability assay, IC50 = 34.6425 μM. |
SANGER |
NCI-H661 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H661 cell growth in a cell viability assay, IC50 = 34.8448 μM. |
SANGER |
YAPC |
Growth Inhibition Assay |
|
|
|
Inhibition of human YAPC cell growth in a cell viability assay, IC50 = 35.9533 μM. |
SANGER |
NCI-H526 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H526 cell growth in a cell viability assay, IC50 = 37.2772 μM. |
SANGER |
A498 |
Growth Inhibition Assay |
|
|
|
Inhibition of human A498 cell growth in a cell viability assay, IC50 = 38.0954 μM. |
SANGER |
VMRC-RCZ |
Growth Inhibition Assay |
|
|
|
Inhibition of human VMRC-RCZ cell growth in a cell viability assay, IC50 = 39.0054 μM. |
SANGER |
HCT-116 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HCT-116 cell growth in a cell viability assay, IC50 = 39.058 μM. |
SANGER |
COLO-320-HSR |
Growth Inhibition Assay |
|
|
|
Inhibition of human COLO-320-HSR cell growth in a cell viability assay, IC50 = 40.041 μM. |
SANGER |
OAW-42 |
Growth Inhibition Assay |
|
|
|
Inhibition of human OAW-42 cell growth in a cell viability assay, IC50 = 40.0542 μM. |
SANGER |
SK-MEL-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SK-MEL-1 cell growth in a cell viability assay, IC50 = 40.2927 μM. |
SANGER |
IST-MES1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human IST-MES1 cell growth in a cell viability assay, IC50 = 40.7653 μM. |
SANGER |
CP50-MEL-B |
Growth Inhibition Assay |
|
|
|
Inhibition of human CP50-MEL-B cell growth in a cell viability assay, IC50 = 41.0797 μM. |
SANGER |
RMG-I |
Growth Inhibition Assay |
|
|
|
Inhibition of human RMG-I cell growth in a cell viability assay, IC50 = 42.4921 μM. |
SANGER |
D-336MG |
Growth Inhibition Assay |
|
|
|
Inhibition of human D-336MG cell growth in a cell viability assay, IC50 = 43.1152 μM. |
SANGER |
SHP-77 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SHP-77 cell growth in a cell viability assay, IC50 = 43.1828 μM. |
SANGER |
SW872 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SW872 cell growth in a cell viability assay, IC50 = 43.2123 μM. |
SANGER |
DBTRG-05MG |
Growth Inhibition Assay |
|
|
|
Inhibition of human DBTRG-05MG cell growth in a cell viability assay, IC50 = 44.6996 μM. |
SANGER |
COLO-678 |
Growth Inhibition Assay |
|
|
|
Inhibition of human COLO-678 cell growth in a cell viability assay, IC50 = 45.7032 μM. |
SANGER |
EGI-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human EGI-1 cell growth in a cell viability assay, IC50 = 47.1833 μM. |
SANGER |
KYSE-70 |
Growth Inhibition Assay |
|
|
|
Inhibition of human KYSE-70 cell growth in a cell viability assay, IC50 = 47.7222 μM. |
SANGER |
BALL-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human BALL-1 cell growth in a cell viability assay, IC50 = 47.8254 μM. |
SANGER |
MDA-MB-361 |
Growth Inhibition Assay |
|
|
|
Inhibition of human MDA-MB-361 cell growth in a cell viability assay, IC50 = 48.046 μM. |
SANGER |
NCI-H1838 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H1838 cell growth in a cell viability assay, IC50 = 48.3458 μM. |
SANGER |
NCI-H1573 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H1573 cell growth in a cell viability assay, IC50 = 48.6785 μM. |
SANGER |
HCC1395 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HCC1395 cell growth in a cell viability assay, IC50 = 48.9919 μM. |
SANGER |
NCI-H2291 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H2291 cell growth in a cell viability assay, IC50 = 49.5988 μM. |
SANGER |
RH-18 |
Growth Inhibition Assay |
|
|
|
Inhibition of human RH-18 cell growth in a cell viability assay, IC50 = 50.0884 μM. |
SANGER |
LU-99A |
Growth Inhibition Assay |
|
|
|
Inhibition of human LU-99A cell growth in a cell viability assay, IC50 = 51.6128 μM. |
SANGER |
NCI-H1693 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H1693 cell growth in a cell viability assay, IC50 = 52.0101 μM. |
SANGER |
TE-12 |
Growth Inhibition Assay |
|
|
|
Inhibition of human TE-12 cell growth in a cell viability assay, IC50 = 52.3319 μM. |
SANGER |
MCF7 |
Growth Inhibition Assay |
|
|
|
Inhibition of human MCF7 cell growth in a cell viability assay, IC50 = 52.8847 μM. |
SANGER |
MMAC-SF |
Growth Inhibition Assay |
|
|
|
Inhibition of human MMAC-SF cell growth in a cell viability assay, IC50 = 53.558 μM. |
SANGER |
COLO-792 |
Growth Inhibition Assay |
|
|
|
Inhibition of human COLO-792 cell growth in a cell viability assay, IC50 = 53.686 μM. |
SANGER |
MKN28 |
Growth Inhibition Assay |
|
|
|
Inhibition of human MKN28 cell growth in a cell viability assay, IC50 = 54.4187 μM. |
SANGER |
PA-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human PA-1 cell growth in a cell viability assay, IC50 = 54.6183 μM. |
SANGER |
SW1088 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SW1088 cell growth in a cell viability assay, IC50 = 56.932 μM. |
SANGER |
NB13 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NB13 cell growth in a cell viability assay, IC50 = 57.5442 μM. |
SANGER |
KLE |
Growth Inhibition Assay |
|
|
|
Inhibition of human KLE cell growth in a cell viability assay, IC50 = 58.3946 μM. |
SANGER |
KYSE-180 |
Growth Inhibition Assay |
|
|
|
Inhibition of human KYSE-180 cell growth in a cell viability assay, IC50 = 58.7833 μM. |
SANGER |
NCI-H1355 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H1355 cell growth in a cell viability assay, IC50 = 59.2853 μM. |
SANGER |
LB2518-MEL |
Growth Inhibition Assay |
|
|
|
Inhibition of human LB2518-MEL cell growth in a cell viability assay, IC50 = 59.8763 μM. |
SANGER |
MFE-280 |
Growth Inhibition Assay |
|
|
|
Inhibition of human MFE-280 cell growth in a cell viability assay, IC50 = 60.9372 μM. |
SANGER |
ALL-PO |
Growth Inhibition Assay |
|
|
|
Inhibition of human ALL-PO cell growth in a cell viability assay, IC50 = 61.2463 μM. |
SANGER |
NCI-H1650 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H1650 cell growth in a cell viability assay, IC50 = 62.3298 μM. |
SANGER |
HCC2218 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HCC2218 cell growth in a cell viability assay, IC50 = 63.3887 μM. |
SANGER |
UMC-11 |
Growth Inhibition Assay |
|
|
|
Inhibition of human UMC-11 cell growth in a cell viability assay, IC50 = 65.4468 μM. |
SANGER |
CCRF-CEM |
Growth Inhibition Assay |
|
|
|
Inhibition of human CCRF-CEM cell growth in a cell viability assay, IC50 = 65.4541 μM. |
SANGER |
NCI-H2030 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H2030 cell growth in a cell viability assay, IC50 = 66.5634 μM. |
SANGER |
EKVX |
Growth Inhibition Assay |
|
|
|
Inhibition of human EKVX cell growth in a cell viability assay, IC50 = 68.1743 μM. |
SANGER |
MSTO-211H |
Growth Inhibition Assay |
|
|
|
Inhibition of human MSTO-211H cell growth in a cell viability assay, IC50 = 68.4406 μM. |
SANGER |
A2058 |
Growth Inhibition Assay |
|
|
|
Inhibition of human A2058 cell growth in a cell viability assay, IC50 = 68.4821 μM. |
SANGER |
MG-63 |
Growth Inhibition Assay |
|
|
|
Inhibition of human MG-63 cell growth in a cell viability assay, IC50 = 69.7565 μM. |
SANGER |
NCI-H630 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H630 cell growth in a cell viability assay, IC50 = 70.4213 μM. |
SANGER |
HCC1569 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HCC1569 cell growth in a cell viability assay, IC50 = 71.0089 μM. |
SANGER |
Capan-2 |
Growth Inhibition Assay |
|
|
|
Inhibition of human Capan-2 cell growth in a cell viability assay, IC50 = 71.0614 μM. |
SANGER |
NCI-H2126 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H2126 cell growth in a cell viability assay, IC50 = 73.4725 μM. |
SANGER |
OS-RC-2 |
Growth Inhibition Assay |
|
|
|
Inhibition of human OS-RC-2 cell growth in a cell viability assay, IC50 = 73.6568 μM. |
SANGER |
COLO-741 |
Growth Inhibition Assay |
|
|
|
Inhibition of human COLO-741 cell growth in a cell viability assay, IC50 = 78.9707 μM. |
SANGER |
ES6 |
Growth Inhibition Assay |
|
|
|
Inhibition of human ES6 cell growth in a cell viability assay, IC50 = 79.1431 μM. |
SANGER |
VA-ES-BJ |
Growth Inhibition Assay |
|
|
|
Inhibition of human VA-ES-BJ cell growth in a cell viability assay, IC50 = 80.7811 μM. |
SANGER |
Mewo |
Growth Inhibition Assay |
|
|
|
Inhibition of human Mewo cell growth in a cell viability assay, IC50 = 80.9653 μM. |
SANGER |
EW-13 |
Growth Inhibition Assay |
|
|
|
Inhibition of human EW-13 cell growth in a cell viability assay, IC50 = 82.0084 μM. |
SANGER |
SK-MEL-30 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SK-MEL-30 cell growth in a cell viability assay, IC50 = 82.0855 μM. |
SANGER |
MFH-ino |
Growth Inhibition Assay |
|
|
|
Inhibition of human MFH-ino cell growth in a cell viability assay, IC50 = 83.5284 μM. |
SANGER |
SW1116 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SW1116 cell growth in a cell viability assay, IC50 = 85.4856 μM. |
SANGER |
LS-513 |
Growth Inhibition Assay |
|
|
|
Inhibition of human LS-513 cell growth in a cell viability assay, IC50 = 88.7976 μM. |
SANGER |
SW1463 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SW1463 cell growth in a cell viability assay, IC50 = 91.6713 μM. |
SANGER |
WM-115 |
Growth Inhibition Assay |
|
|
|
Inhibition of human WM-115 cell growth in a cell viability assay, IC50 = 92.9267 μM. |
SANGER |
A2780 |
Growth Inhibition Assay |
|
|
|
Inhibition of human A2780 cell growth in a cell viability assay, IC50 = 93.6595 μM. |
SANGER |
PANC-10-05 |
Growth Inhibition Assay |
|
|
|
Inhibition of human PANC-10-05 cell growth in a cell viability assay, IC50 = 93.9708 μM. |
SANGER |
NCI-H1623 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H1623 cell growth in a cell viability assay, IC50 = 95.7976 μM. |
SANGER |
COLO-668 |
Growth Inhibition Assay |
|
|
|
Inhibition of human COLO-668 cell growth in a cell viability assay, IC50 = 96.9094 μM. |
SANGER |
HCC2157 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HCC2157 cell growth in a cell viability assay, IC50 = 97.0782 μM. |
SANGER |
OC-314 |
Growth Inhibition Assay |
|
|
|
Inhibition of human OC-314 cell growth in a cell viability assay, IC50 = 98.494 μM. |
SANGER |
SK-MEL-24 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SK-MEL-24 cell growth in a cell viability assay, IC50 = 99.3301 μM. |
SANGER |
HCC2998 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HCC2998 cell growth in a cell viability assay, IC50 = 101.05 μM. |
SANGER |
NCI-H2170 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H2170 cell growth in a cell viability assay, IC50 = 102.933 μM. |
SANGER |
HT-1197 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HT-1197 cell growth in a cell viability assay, IC50 = 103.494 μM. |
SANGER |
HCT-15 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HCT-15 cell growth in a cell viability assay, IC50 = 105.399 μM. |
SANGER |
MKN45 |
Growth Inhibition Assay |
|
|
|
Inhibition of human MKN45 cell growth in a cell viability assay, IC50 = 105.597 μM. |
SANGER |
SW13 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SW13 cell growth in a cell viability assay, IC50 = 105.968 μM. |
SANGER |
RO82-W-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human RO82-W-1 cell growth in a cell viability assay, IC50 = 107.765 μM. |
SANGER |
JAR |
Growth Inhibition Assay |
|
|
|
Inhibition of human JAR cell growth in a cell viability assay, IC50 = 108.694 μM. |
SANGER |
ESS-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human ESS-1 cell growth in a cell viability assay, IC50 = 114.118 μM. |
SANGER |
LS-1034 |
Growth Inhibition Assay |
|
|
|
Inhibition of human LS-1034 cell growth in a cell viability assay, IC50 = 118.609 μM. |
SANGER |
BFTC-909 |
Growth Inhibition Assay |
|
|
|
Inhibition of human BFTC-909 cell growth in a cell viability assay, IC50 = 120.485 μM. |
SANGER |
TGBC24TKB |
Growth Inhibition Assay |
|
|
|
Inhibition of human TGBC24TKB cell growth in a cell viability assay, IC50 = 124.298 μM. |
SANGER |
T-24 |
Growth Inhibition Assay |
|
|
|
Inhibition of human T-24 cell growth in a cell viability assay, IC50 = 125.66 μM. |
SANGER |
J82 |
Growth Inhibition Assay |
|
|
|
Inhibition of human J82 cell growth in a cell viability assay, IC50 = 129.014 μM. |
SANGER |
AM-38 |
Growth Inhibition Assay |
|
|
|
Inhibition of human AM-38 cell growth in a cell viability assay, IC50 = 129.407 μM. |
SANGER |
MDA-MB-453 |
Growth Inhibition Assay |
|
|
|
Inhibition of human MDA-MB-453 cell growth in a cell viability assay, IC50 = 130.177 μM. |
SANGER |
U-2-OS |
Growth Inhibition Assay |
|
|
|
Inhibition of human U-2-OS cell growth in a cell viability assay, IC50 = 130.803 μM. |
SANGER |
NCI-H1666 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H1666 cell growth in a cell viability assay, IC50 = 131.615 μM. |
SANGER |
DOHH-2 |
Growth Inhibition Assay |
|
|
|
Inhibition of human DOHH-2 cell growth in a cell viability assay, IC50 = 131.981 μM. |
SANGER |
U031 |
Growth Inhibition Assay |
|
|
|
Inhibition of human U031 cell growth in a cell viability assay, IC50 = 139.51 μM. |
SANGER |
A673 |
Growth Inhibition Assay |
|
|
|
Inhibition of human A673 cell growth in a cell viability assay, IC50 = 140.714 μM. |
SANGER |
NCI-H1793 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H1793 cell growth in a cell viability assay, IC50 = 142.235 μM. |
SANGER |
BxPC-3 |
Growth Inhibition Assay |
|
|
|
Inhibition of human BxPC-3 cell growth in a cell viability assay, IC50 = 144.449 μM. |
SANGER |
SW837 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SW837 cell growth in a cell viability assay, IC50 = 145.887 μM. |
SANGER |
HT-29 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HT-29 cell growth in a cell viability assay, IC50 = 148.287 μM. |
SANGER |
MZ7-mel |
Growth Inhibition Assay |
|
|
|
Inhibition of human MZ7-mel cell growth in a cell viability assay, IC50 = 149.332 μM. |
SANGER |
SW620 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SW620 cell growth in a cell viability assay, IC50 = 152.783 μM. |
SANGER |
GAK |
Growth Inhibition Assay |
|
|
|
Inhibition of human GAK cell growth in a cell viability assay, IC50 = 157.274 μM. |
SANGER |
CAS-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human CAS-1 cell growth in a cell viability assay, IC50 = 161.861 μM. |
SANGER |
HuP-T3 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HuP-T3 cell growth in a cell viability assay, IC50 = 164.025 μM. |
SANGER |
K-562 |
Growth Inhibition Assay |
|
|
|
Inhibition of human K-562 cell growth in a cell viability assay, IC50 = 166.999 μM. |
SANGER |
KP-4 |
Growth Inhibition Assay |
|
|
|
Inhibition of human KP-4 cell growth in a cell viability assay, IC50 = 176.133 μM. |
SANGER |
LB771-HNC |
Growth Inhibition Assay |
|
|
|
Inhibition of human LB771-HNC cell growth in a cell viability assay, IC50 = 177.514 μM. |
SANGER |
BCPAP |
Growth Inhibition Assay |
|
|
|
Inhibition of human BCPAP cell growth in a cell viability assay, IC50 = 178.122 μM. |
SANGER |
NCI-N87 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-N87 cell growth in a cell viability assay, IC50 = 181.488 μM. |
SANGER |
H-EMC-SS |
Growth Inhibition Assay |
|
|
|
Inhibition of human H-EMC-SS cell growth in a cell viability assay, IC50 = 202.692 μM. |
SANGER |
D-263MG |
Growth Inhibition Assay |
|
|
|
Inhibition of human D-263MG cell growth in a cell viability assay, IC50 = 207.067 μM. |
SANGER |
LB373-MEL-D |
Growth Inhibition Assay |
|
|
|
Inhibition of human LB373-MEL-D cell growth in a cell viability assay, IC50 = 207.487 μM. |
SANGER |
SF295 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SF295 cell growth in a cell viability assay, IC50 = 212.709 μM. |
SANGER |
BT-20 |
Growth Inhibition Assay |
|
|
|
Inhibition of human BT-20 cell growth in a cell viability assay, IC50 = 214.977 μM. |
SANGER |
SK-LMS-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SK-LMS-1 cell growth in a cell viability assay, IC50 = 217.946 μM. |
SANGER |
HCE-T |
Growth Inhibition Assay |
|
|
|
Inhibition of human HCE-T cell growth in a cell viability assay, IC50 = 220.414 μM. |
SANGER |
NCI-H522 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H522 cell growth in a cell viability assay, IC50 = 220.593 μM. |
SANGER |
DK-MG |
Growth Inhibition Assay |
|
|
|
Inhibition of human DK-MG cell growth in a cell viability assay, IC50 = 228.077 μM. |
SANGER |
HDLM-2 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HDLM-2 cell growth in a cell viability assay, IC50 = 228.889 μM. |
SANGER |
RPMI-8866 |
Growth Inhibition Assay |
|
|
|
Inhibition of human RPMI-8866 cell growth in a cell viability assay, IC50 = 234.422 μM. |
SANGER |
SBC-5 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SBC-5 cell growth in a cell viability assay, IC50 = 235.457 μM. |
SANGER |
NCI-H441 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H441 cell growth in a cell viability assay, IC50 = 241.801 μM. |
SANGER |
HCC1937 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HCC1937 cell growth in a cell viability assay, IC50 = 244.754 μM. |
SANGER |
CAKI-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human CAKI-1 cell growth in a cell viability assay, IC50 = 256.034 μM. |
SANGER |
SW1417 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SW1417 cell growth in a cell viability assay, IC50 = 259.036 μM. |
SANGER |
ONS-76 |
Growth Inhibition Assay |
|
|
|
Inhibition of human ONS-76 cell growth in a cell viability assay, IC50 = 265.052 μM. |
SANGER |
HCC1419 |
Growth Inhibition Assay |
|
|
|
Inhibition of human HCC1419 cell growth in a cell viability assay, IC50 = 266.025 μM. |
SANGER |
A4-Fuk |
Growth Inhibition Assay |
|
|
|
Inhibition of human A4-Fuk cell growth in a cell viability assay, IC50 = 266.655 μM. |
SANGER |
SW1990 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SW1990 cell growth in a cell viability assay, IC50 = 270.481 μM. |
SANGER |
EFO-21 |
Growth Inhibition Assay |
|
|
|
Inhibition of human EFO-21 cell growth in a cell viability assay, IC50 = 279.176 μM. |
SANGER |
COR-L105 |
Growth Inhibition Assay |
|
|
|
Inhibition of human COR-L105 cell growth in a cell viability assay, IC50 = 303.984 μM. |
SANGER |
AsPC-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human AsPC-1 cell growth in a cell viability assay, IC50 = 316.889 μM. |
SANGER |
T84 |
Growth Inhibition Assay |
|
|
|
Inhibition of human T84 cell growth in a cell viability assay, IC50 = 325.443 μM. |
SANGER |
ABC-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human ABC-1 cell growth in a cell viability assay, IC50 = 335.897 μM. |
SANGER |
NCI-H226 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H226 cell growth in a cell viability assay, IC50 = 366.683 μM. |
SANGER |
UACC-893 |
Growth Inhibition Assay |
|
|
|
Inhibition of human UACC-893 cell growth in a cell viability assay, IC50 = 368.948 μM. |
SANGER |
OAW-28 |
Growth Inhibition Assay |
|
|
|
Inhibition of human OAW-28 cell growth in a cell viability assay, IC50 = 383.493 μM. |
SANGER |
NMC-G1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NMC-G1 cell growth in a cell viability assay, IC50 = 395.947 μM. |
SANGER |
NCI-H1563 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H1563 cell growth in a cell viability assay, IC50 = 398.096 μM. |
SANGER |
SW900 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SW900 cell growth in a cell viability assay, IC50 = 401.326 μM. |
SANGER |
SW948 |
Growth Inhibition Assay |
|
|
|
Inhibition of human SW948 cell growth in a cell viability assay, IC50 = 411.094 μM. |
SANGER |
CAPAN-1 |
Growth Inhibition Assay |
|
|
|
Inhibition of human CAPAN-1 cell growth in a cell viability assay, IC50 = 411.292 μM. |
SANGER |
UACC-257 |
Growth Inhibition Assay |
|
|
|
Inhibition of human UACC-257 cell growth in a cell viability assay, IC50 = 433.155 μM. |
SANGER |
ZR-75-30 |
Growth Inhibition Assay |
|
|
|
Inhibition of human ZR-75-30 cell growth in a cell viability assay, IC50 = 449.934 μM. |
SANGER |
NCI-H1993 |
Growth Inhibition Assay |
|
|
|
Inhibition of human NCI-H1993 cell growth in a cell viability assay, IC50 = 480.264 μM. |
SANGER |
LB996-RCC |
Growth Inhibition Assay |
|
|
|
Inhibition of human LB996-RCC cell growth in a cell viability assay, IC50 = 495.241 μM. |
SANGER |
L-428 |
Growth Inhibition Assay |
|
|
|
Inhibition of human L-428 cell growth in a cell viability assay, IC50 = 554.78 μM. |
SANGER |
C3A |
Growth Inhibition Assay |
|
|
|
Inhibition of human C3A cell growth in a cell viability assay, IC50 = 563.78 μM. |
SANGER |